Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Doria

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Diabetes & Metabolism|April 29, 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetesSerena Pezzilli, Manoush Tohidirad, Tommaso Biagini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 10, 2025
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease TreatmentAndrzej S Krolewski, Jani K Haukka, Zaipul I Md Dom, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Diabetes|March 3, 2009
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetesMarcus G Pezzolesi, G David Poznik, Josyf C Mychaleckyj, et al.
The New England Journal of Medicine|September 23, 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without RaceLesley A Inker, Nwamaka D Eneanya, Josef Coresh, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Diabetes|July 10, 2013
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetesHanieh Yaghootkar, Claudia Lamina, Robert A Scott, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Diabetes & Metabolism|April 29, 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetesSerena Pezzilli, Manoush Tohidirad, Tommaso Biagini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 10, 2025
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease TreatmentAndrzej S Krolewski, Jani K Haukka, Zaipul I Md Dom, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Diabetes|January 25, 2020
<i>PPARA</i> Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Diabetes|March 3, 2009
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetesMarcus G Pezzolesi, G David Poznik, Josyf C Mychaleckyj, et al.
The New England Journal of Medicine|September 23, 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without RaceLesley A Inker, Nwamaka D Eneanya, Josef Coresh, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Diabetes|July 10, 2013
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetesHanieh Yaghootkar, Claudia Lamina, Robert A Scott, et al.
Pageof 14